Literature DB >> 16410030

Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers.

Eva-Maria Collnot1, Christiane Baldes, Michael F Wempe, John Hyatt, Lisa Navarro, Kevin J Edgar, Ulrich Friedrich Schaefer, Claus-Michael Lehr.   

Abstract

D-alpha-tocopheryl poly(ethylene glycol) 1000 succinate (TPGS 1000) is a widely used form of vitamin E. TPGS 1000 is comprised of a hydrophilic polar (water-soluble) head and a lipophilic (water-insoluble) alkyl tail. TPGS 1000 has been used as a solubilizer, an emulsifier and as a vehicle for lipid-based drug delivery formulations. Most recently, TPGS 1000 has been recognized as an effective oral absorption enhancer. An enhancing effect is consistent with a surfactant-induced inhibition of P-glycoprotein (P-gp), and perhaps other drug transporter proteins; however, the exact inhibition mechanism(s) remain unclear. Therefore, in an attempt to generate additional knowledge, we have synthesized and tested various TPGS analogs containing different PEG chain length (TPGS 200/238/400/600/1000/2000/3400/3500/4000/6000). These results demonstrate a relationship between TPGS PEG chain length and influence on rhodamine 123 (RHO) transport in Caco-2 monolayers, a relationship which may be illustrated using a Weibull distribution.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16410030     DOI: 10.1016/j.jconrel.2005.11.005

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  34 in total

1.  Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats.

Authors:  Wei Chen; Yu-Qiang Miao; Dong-Jiao Fan; Shen-Shen Yang; Xia Lin; Ling-Kuo Meng; Xing Tang
Journal:  AAPS PharmSciTech       Date:  2011-06-03       Impact factor: 3.246

2.  Physiological modeling to understand the impact of enzymes and transporters on drug and metabolite data and bioavailability estimates.

Authors:  Huadong Sun; K Sandy Pang
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 3.  Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Authors:  Xiaowei Dong; Russell J Mumper
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

Review 4.  Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.

Authors:  Angel Tan; Shasha Rao; Clive A Prestidge
Journal:  Pharm Res       Date:  2013-06-18       Impact factor: 4.200

Review 5.  Vitamin E-derived copolymers continue the challenge to hemodialysis biomaterials.

Authors:  Francesco Galli
Journal:  World J Nephrol       Date:  2012-08-06

6.  A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles.

Authors:  Olcay Mert; Samuel K Lai; Laura Ensign; Ming Yang; Ying-Ying Wang; Joseph Wood; Justin Hanes
Journal:  J Control Release       Date:  2011-09-03       Impact factor: 9.776

7.  Vitamin E reverses multidrug resistance in vitro and in vivo.

Authors:  Jingling Tang; Qiang Fu; Yongjun Wang; Kelly Racette; Dun Wang; Feng Liu
Journal:  Cancer Lett       Date:  2013-04-23       Impact factor: 8.679

Review 8.  Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.

Authors:  Zhiyong Wang; Gang Liu; Hairong Zheng; Xiaoyuan Chen
Journal:  Biotechnol Adv       Date:  2013-09-05       Impact factor: 14.227

9.  Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified carrier for oral delivery: an approach for non-toxic chemotherapy.

Authors:  Pramod K Gupta; Anil K Jaiswal; Shalini Asthana; Venkatesh Teja B; Prashant Shukla; Minakshi Shukla; Neeti Sagar; Anuradha Dube; Srikanta K Rath; Prabhat R Mishra
Journal:  Br J Pharmacol       Date:  2015-05-19       Impact factor: 8.739

10.  Key structure of brij for overcoming multidrug resistance in cancer.

Authors:  Jingling Tang; Yongjun Wang; Dun Wang; Yuhua Wang; Zhenghong Xu; Kelly Racette; Feng Liu
Journal:  Biomacromolecules       Date:  2013-01-24       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.